Xoc Pharmaceuticals Competitors and Similar CompaniesClear all

Xoc Pharmaceuticals's competitors and similar companies include Teva Pharmaceuticals, LTS Lohmann Therapie-Systeme, Esteve and Emergent Biosolutions.

	Xoc Pharmaceuticals Xoc Pharmaceuticals is a biopharmaceutical company focused on the development of innovative therapeutics.	Teva Pharmaceuticals Teva Pharmaceuticals is a global pharmaceutical company.	LTS Lohmann Therapie-Systeme LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.	Esteve Esteve is a company that manufactures and supplies pharmaceuticals.	Emergent Biosolutions Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats.
Founding Date	Founding Date 2013	Founding Date 1901	Founding Date 1984	Founding Date 1929	Founding Date 1998
Type	Type Private	Type Public	Type Subsidiary	Type Private	Type Public
Tags	Tags Healthcare drug development medtech pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development medtech pharma therapy
Locations	Locations Los Gatos, US HQ	Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more	Locations Andernach, DE HQ Shanghai, CN West Caldwell, US	Locations Barcelona, ES HQ Shaoxing, CN Paris, FR Berlin, DE Milan, IT Lisbon, PT Barcelona, ES see more	Locations Gaithersburg, US HQ Mississauga, CA Winnipeg, CA Dublin, IE London, GB Canton, US Lansing, US see more
Employees	Employees N/A	Employees 37,000	Employees 2991% increase	Employees 2,0063% increase	Employees 90044% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 20.8 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 493.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $17.3b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $742.9m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $8.3b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $326.2m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $8.9b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $416.7m (FY, 2025)
Net income	Net income N/A	Net income $1.4b (FY, 2025)	Net income N/A	Net income N/A	Net income $52.6m (FY, 2025)
Funding
Total funding raised	Total funding raised $ 30m	Total funding raised $ 358m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 34.5m